- Home
- BCDA vs JCTC Comparison
BCDA vs JCTC Comparison
Compare BCDA & JCTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCDA
- JCTC
- Stock Information
- Founded
- BCDA N/A
- JCTC 1953
- Country
- BCDA United States
- JCTC United States
- Employees
- BCDA N/A
- JCTC N/A
- Industry
- BCDA Biotechnology: Pharmaceutical Preparations
- JCTC
- Sector
- BCDA Health Care
- JCTC
- Exchange
- BCDA Nasdaq
- JCTC NYSE
- Market Cap
- BCDA 11.0M
- JCTC 13.2M
- IPO Year
- BCDA N/A
- JCTC 1996
- Fundamental
- Price
- BCDA $2.12
- JCTC $3.70
- Analyst Decision
- BCDA Strong Buy
- JCTC
- Analyst Count
- BCDA 1
- JCTC 0
- Target Price
- BCDA $25.00
- JCTC N/A
- AVG Volume (30 Days)
- BCDA 204.0K
- JCTC 3.6K
- Earning Date
- BCDA 08-12-2025
- JCTC 07-14-2025
- Dividend Yield
- BCDA N/A
- JCTC N/A
- EPS Growth
- BCDA N/A
- JCTC N/A
- EPS
- BCDA N/A
- JCTC N/A
- Revenue
- BCDA $3,000.00
- JCTC $47,432,094.00
- Revenue This Year
- BCDA N/A
- JCTC N/A
- Revenue Next Year
- BCDA N/A
- JCTC N/A
- P/E Ratio
- BCDA N/A
- JCTC N/A
- Revenue Growth
- BCDA N/A
- JCTC N/A
- 52 Week Low
- BCDA $1.63
- JCTC $3.26
- 52 Week High
- BCDA $4.66
- JCTC $5.41
- Technical
- Relative Strength Index (RSI)
- BCDA 44.60
- JCTC N/A
- Support Level
- BCDA $1.98
- JCTC N/A
- Resistance Level
- BCDA $2.45
- JCTC N/A
- Average True Range (ATR)
- BCDA 0.16
- JCTC 0.00
- MACD
- BCDA -0.01
- JCTC 0.00
- Stochastic Oscillator
- BCDA 18.00
- JCTC 0.00
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
About JCTC JEWETT-CAMERON TRADING CO
Jewett-Cameron Trading Co Ltd through its subsidiaries engages in the wholesale distribution of a variety of specialty wood products. Its operating segments include, The Industrial wood products segment is engaged in the processing and distribution of industrial wood products. The Pet Fencing and Other segment, which is the key revenue driver, operates as a wholesaler of wood products and a manufacturer and distributor of specialty metal products. The Seed processing and sales segment processes and distributes agricultural seed and Corporate and administrative. The company predominantly operates in the United States and also has a presence in Canada, Latin America, Europe and Asia Pacific, and other regions.